|
|
Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug
Jacques Gottenberg
,
Olivier Brocq
,
Aleth Perdriger
,
Slim Lassoued
,
Jean Berthelot
,
et al.
Journal articles
hal-01374313v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
Ludovic Trefond
,
Elodie Drumez
,
Marc Andre
,
Nathalie Costedoat-Chalumeau
,
Raphaèle Seror
,
et al.
Journal articles
hal-03318617v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Jose Smolen
,
Robert Landewé
,
Johannes W Bijlsma
,
Gerd Burmester
,
Katerina Chatzidionysiou
,
et al.
Journal articles
hal-01778213v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High risk of osteoporotic fracture in Parkinson's disease: Meta-analysis, pathophysiology and management
M. Louvois
,
S. Ferrero
,
T. Barnetche
,
C.H. Roux
,
V. Breuil
Journal articles
cea-03628016v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients
Laure Gossec
,
Martin Soubrier
,
Frantz Foissac
,
Anna Moltó
,
Pascal Richette
,
et al.
Journal articles
hal-02413173v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France
Laure Gossec
,
Athan Baillet
,
Sabrina Dadoun
,
Claire Daien
,
Francis Berenbaum
,
et al.
Journal articles
hal-01340133v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|